Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-17 | Stoke Therapeutics, Inc. | Montrago Trustees...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 3600000 | $11.60 - $11.60 | $41,760,000 |
2024-03-19 | Stoke Therapeutics, Inc. | Tulipano Stephen J
(CFO) |
S | Common Stock | D | 4116 | $6.10 - $6.10 | $25,101 |
2024-03-15 | Stoke Therapeutics, Inc. | Tulipano Stephen J
(CFO) |
M | Common Stock | A | 13100 | $0.00 - $0.00 | $0 |
2024-03-19 | Stoke Therapeutics, Inc. | Ticho Barry
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 4116 | $6.10 - $6.10 | $25,101 |
2024-03-15 | Stoke Therapeutics, Inc. | Ticho Barry
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 13100 | $0.00 - $0.00 | $0 |
2024-03-19 | Stoke Therapeutics, Inc. | Nash Huw M.
(COO & CBO) |
S | Common Stock | D | 4116 | $6.10 - $6.10 | $25,101 |
2024-03-15 | Stoke Therapeutics, Inc. | Nash Huw M.
(COO & CBO) |
M | Common Stock | A | 13100 | $0.00 - $0.00 | $0 |
2024-03-19 | Stoke Therapeutics, Inc. | Kaye Edward M. MD
(CEO) |
S | Common Stock | D | 11150 | $6.10 - $6.10 | $67,999 |
2024-03-15 | Stoke Therapeutics, Inc. | Kaye Edward M. MD
(CEO) |
M | Common Stock | A | 35500 | $0.00 - $0.00 | $0 |
2024-03-19 | Stoke Therapeutics, Inc. | Allan Jonathan
(GENERAL COUNSEL & CORP SEC) |
S | Common Stock | D | 2349 | $6.10 - $6.10 | $14,325 |
2024-03-15 | Stoke Therapeutics, Inc. | Allan Jonathan
(GENERAL COUNSEL & CORP SEC) |
M | Common Stock | A | 7475 | $0.00 - $0.00 | $0 |
2024-02-13 | Stoke Therapeutics, Inc. | TZIANABOS ARTHUR
(Director) |
M | Common Stock | A | 31739 | $2.19 - $2.19 | $69,508 |
2024-01-02 | Stoke Therapeutics, Inc. | Ticho Barry
(Chief Medical Officer) |
S | Common Stock | D | 10000 | $5.74 - $5.74 | $57,352 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |